Furthermore, CP-24879 treatment induced a dose-dependent increase in CD11b expression and annexin-V positivity in both NOMO1 and THP-1 AML cell lines (Fig. S5, B and C). This evidence concerns the gene ITGAM and acute myeloid leukemia.